References
- Burstein M., Scholnick H. R., Mortin R. Rapid method for the isolation of lipoprotein from human serum precipitation by polyanions. J. Lipid Res. 1970; 11: 583
- Day I. L., Simpson N., Metcalfe J., Page R. I. Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Br. med. J. 1979; 1: 77
- Devenyi P., Robinson G. M., Roncari D. A.K. Alcohol and high-density lipoproteins. Can. med. Ass. J. 1980; 123: 981
- Eggstein M., Kreutz F. H. Eine neue bestimmung der neutralfette im blutserum und gewebe. Klin. Wschr. 1966; 44: 262
- Enger S. C., Hjermann I., Foss O. P., Helgeland A., Holme I., Leren P., Norum K. R. High density lipoprotein cholesterol and myocardial infarction and sudden coronary death: a prospective case-control study in middle-aged men of the Oslo Study. Artery 1979; 5: 170
- England D. F., Simons L. A., Gibson J. C., Carlton M. The effect of metoprolol and atenolol on plasma high-density-lipoprotein levels in man. Clin. exp. Pharmac. Physiol. 1980; 7: 329
- Garrison R. J., Kannel W. B., Feinleib M., Castelli W. P., McNamara P. M., Padgett S. J. Cigarette smoking and HDL-cholesterol: the Framingham offspring study. Atherosclerosis 1978; 30: 17
- Helgeland A., Hjermann I., Leren P., Enger S., Holme I. High-density lipoprotein cholesterol and antihypertensive drugs. The Oslo Study. Br. med. J. 1978; 2: 403
- Inkeles S., Eisenberg D. Hyperlipidemia and coronary atherosclerosis: a review. Medicine 1981; 60: 110
- Kannel W. B., Castelli W. P., Gordon T. Cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framingham study. Ann. intern. Med. 1979; 90: 85
- Kristensen B. Ø. Effect of long-term treatment with beta-blocking drugs on plasma lipids and lipoproteins. Br. med. J. 1981; 2: 191
- Lehtonen A., Viikari J. Serum triglycerides and cholesterol and serum high-density lipoprotein cholesterol in highly physically active men. Acta med. scand. 1978; 204: 111
- Leren P., Eide I., Foss O. P., Helgeland A., Hjermann I., Holme I., Kjeldsen S. E., Lund-Larsen P. G. Antihypertensive drugs and blood lipids: the Oslo Study. Brit. J. clin. Pharmac. 1982, in press
- Leren P., Foss O. P., Helgeland A., Hjermann I., Holme I. Effect of pindolol and hydrochlorothiazide on blood lipids. The Oslo Study. Clin. Trials J. 1981; 18: 254
- Leren P., Foss O. P., Helgeland A., Hjermann I., Holme I., Lund-Larsen P. G. Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet 1980; ii: 4
- Miller N. E., Thelle D. S., Førde O. H., Mjøs O. D. The Tromsø heart study. High density lipoproteins and coronary heart disease: a prospective case-control study. Lancet 1977; i: 965
- Mjøs O. D. Editorial: High density lipoprotein and coronary heart disease. Scand. J. clin. Lab. Invest. 1977; 37: 191
- Rhoads G. G., Gulbrandsen C. L., Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. New Engl. J. Med. 1976; 294: 293
- Röschlau P., Bernt E., Gruber W. Enzymatische bestimmung des gesamt-cholesterin in serum. Z. klin. Chem. 1974; 12: 403
- Rössner S., Hallberg D. Serum lipoproteins in massive obesity. Acta med. scand. 1978; 204: 103
- Shaw J., England J. D.F., Hua A. S.P. Beta-blockers and plasma triglycerides. Br. med. J. 1979; 1: 968
- Tanaka N., Sagagushi K., Oshige K., Niimura T., Kanehisa T. Effect of chronic administration of propranolol on lipoprotein composition. Meta-bolism 1976; 25: 1071
- Weiner L., Rössner S. Blodtrycksbehandling med 50 mg atenolol eller 200 mg metoprolol—en jämförelse med avseende på blodtryck, biverkningar och lipoproteineffecter. Svenska Läkaresällskapets Handlingar 1981; 90(5)110
- Waal-Manning H. J. Drugs 1976; 11(Suppl. I)1–121